Try our beta test site
18 studies found for:    esperion
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
Condition: Hypercholesterolemia
Interventions: Drug: Bempedoic acid 180mg;   Drug: Ezetimibe 10mg;   Drug: Atorvastatin 20mg;   Other: Placebo
2 Recruiting Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
Conditions: Hypercholesterolemia;   Atherosclerosis;   Statin Adverse Reaction
Interventions: Drug: Bempedoic acid;   Drug: Ezetimibe;   Other: Placebo
3 Recruiting Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Conditions: Cardiovascular Diseases;   Statin Adverse Reaction
Interventions: Drug: Bempedoic acid 180 mg tablet;   Drug: Matching placebo tablet
4 Recruiting Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Disease
Interventions: Drug: bempedoic acid;   Drug: placebo
5 Recruiting Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Disease;   Statin Adverse Reaction
Interventions: Drug: bempedoic acid;   Other: placebo
6 Completed A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
Condition: Mild Dyslipidemia
Intervention: Drug: ETC-1002 or placebo
7 Enrolling by invitation Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Disease
Intervention: Drug: bempedoic acid
8 Active, not recruiting Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
Conditions: Hypercholesterolemia;   Atherosclerotic Cardiovascular Diseases
Interventions: Drug: ETC-1002;   Drug: Placebo
9 Completed A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Condition: Hyperlipidemia
Interventions: Drug: ETC-1002;   Drug: Atorvastatin;   Drug: Placebo
10 Completed Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo;   Drug: Statin Therapy
11 Completed Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Ezetimibe
12 Completed A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo;   Drug: Atorvastatin
13 Completed A Study of the Efficacy and Safety of ETC-1002 in Subjects With Statin Intolerance
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo
14 Completed Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Conditions: Hypercholesterolemia;   Hypertension
Interventions: Drug: ETC-1002;   Drug: Placebo
15 Completed Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002
Condition: Hyperlipidemia
Intervention: Drug: [14C-ETC-1002]
16 Completed A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes
Conditions: Hyperlipidemia;   Type 2 Diabetes
Interventions: Drug: ETC-1002;   Drug: Placebo
17 Completed A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects
Condition: Safety Evaluation of Escalating Doses
Intervention: Drug: ETC-1002
18 Completed A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides
Condition: Dyslipidemia
Interventions: Drug: ETC-1002;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.